Cell isolation and separation is the process of separating individual living cells from one another within a biological sample such as blood or tissue. Cell isolation and separation techniques comprise centrifugation, FACS (fluorescence-activated cell sorting), BACS (buoyancy-activated cell sorting), MACS (magnetic-activated cell sorting), and microfluidics or filtration. There are three types of cell separation approaches positive selection, negative selection, and depletion. Increasing funding from the government and biotechnology companies for cell-based research, coupled with growing biotechnology and biopharmaceutical companies, is supporting market growth. For example, the National Institutes of Health (NIH) invested $1,646 million in stem cell research in 2017, with another $1 billion expected to be spent by 2019. In addition, the globally rising prevalence of cancer and infectious diseases, along with augmenting demand for personalized medicine, is anticipated to assist in market growth during the forecast period.
The consumables segment is expected to spearhead the market owing to the repetitive demand for these products for research and diagnostics applications due to their limited durability. Increasing adoption of centrifugation technology for the manufacturing of biopharmaceutical drugs, proteins, vaccines, and antibodies will hold a major chunk of the market in the near future. Based on type, the human cells segment dominates the market due to the rising applications of isolated human cells in biopharmaceutical development, research, and clinical trials.
The presence of major market participants, biopharmaceutical companies, and research laboratories, along with sophisticated infrastructure in the U.S. and Canada, has placed North America in the dominant position. On the other hand, Asia Pacific is expected to register a comparatively higher CAGR from 2018 to 2026 due to the rising prevalence of cancer and infectious diseases among individuals and favorable government support for research activities.
The global cell isolation and separation market is segmented on the following basis:
Global Cell Isolation and Separation Market, by Product, 2016–2026 (US$ Mn)
Consumables
Media, Reagents, Kits, and Sera
Beads
Disposables
Instruments
Centrifuges
Flow Cytometers
Magnetic-activated cell sorting (MACS) systems
Filtration Systems
Global Cell Isolation and Separation Market, by Technique, 2016–2026 (US$ Mn)
Surface Marker
Filtration
Centrifugation
Global Cell Isolation and Separation Market, by Type, 2016–2026 (US$ Mn)
Human Cells
Animal Cells
Global Cell Isolation and Separation Market, by Application, 2016–2026 (US$ Mn)
Research Laboratories and Institutes
Biotechnology and Biopharmaceutical Companies
Cell Banks
Hospital and Diagnostic Laboratories
Global Cell Isolation and Separation Market, by Geography, 2016–2026 (US$ Mn)
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Key players identified in the global cell isolation and separation market include:
Thermo Fisher Scientific Inc.
BD Biosciences
STEMCELL Technologies, Inc.
Merck KGaA
GE Healthcare
Bio-Rad Laboratories, Inc.
Terumo BCT, Inc.
pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
Miltenyi Biotec GmbH
BioLegend, Inc.
This report offers the following:
Comprehensive overview of the global cell isolation and separation market, including the current market dynamics.
Elucidation of each market segment based on product approvals, launches, and current and anticipated market dynamics
Company profiles and the competitive landscape of market leaders operating in the cell isolation and separation market, comprising key products, operating business areas, and financial analysis
Frequently Asked Question:
The market for Cell Isolation and Separation Market is expected to reach USD$ XX Mn in 2026.
The Cell Isolation and Separation Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2018 -2026.
The base year of this report is 2017.
Thermo Fisher Scientific Inc.,BD Biosciences,STEMCELL Technologies, Inc.,Merck KGaA,GE Healthcare,Bio-Rad Laboratories, Inc.,Terumo BCT, Inc. are some of the major players in the global market.
